Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/05/2020 08/06/2020 08/07/2020 08/10/2020 08/11/2020 Date
400.74(c) 399.33(c) 355.66(c) 353.35(c) 345.9 Last
526 789 853 082 4 266 388 951 215 530 217 Volume
+1.79% -0.35% -10.94% -0.65% -2.11% Change
More quotes
Financials (USD)
Sales 2020 3 135 M - -
Net income 2020 578 M - -
Net cash position 2020 2 344 M - -
P/E ratio 2020 93,2x
Yield 2020 -
Sales 2021 4 001 M - -
Net income 2021 1 040 M - -
Net cash position 2021 3 043 M - -
P/E ratio 2021 50,6x
Yield 2021 -
Capitalization 51 589 M 51 589 M -
EV / Sales 2020 15,7x
EV / Sales 2021 12,1x
Nbr of Employees 7 700
Free-Float 74,5%
More Financials
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (82.7%): tools and... 
Sector
Advanced Medical Equipment & Technology
Calendar
08/12 | 01:00pmPresentation
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
09:01aILLUMINA : Wouter Meuleman Promoted to Partner of Illumina Ventures
PR
08/07Zillow, Stamps.com rise; Uber, Illumina fall
AQ
08/07ILLUMINA : to Webcast Upcoming Investor Conference Presentation
BU
08/07ILLUMINA : Court Upholds Patent Eligibility Of "Method Of Preparation" Claims In..
AQ
08/06ILLUMINA : Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discov..
BU
08/06ILLUMINA : Reports Drop in 2Q Results Amid Pandemic -- Earnings Review
DJ
08/06ILLUMINA : 2Q Earnings Snapshot
AQ
08/06ILLUMINA : Reports Financial Results for Second Quarter of Fiscal Year 2020
BU
08/06ILLUMINA, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
08/05SPECIAL REPORT : COVID opens new doors for China's gene giant
RE
08/03ILLUMINA, INC. : half-yearly earnings release
07/16ILLUMINA : to Announce Second Quarter 2020 Financial Results on Thursday, August..
BU
07/08ILLUMINA : Launches TruSight Software Suite to Accelerate the Identification of ..
BU
06/23ILLUMINA : Accelerator Welcomes First Global Cohort of Genomics Startups
BU
06/17ILLUMINA : Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Ne..
BU
More news
News in other languages on ILLUMINA, INC.
09:01aILLUMINA : Wouter Meuleman Promoted to Partner of Illumina Ventures
08/07Zillow, Stamps.com rise; Uber, Illumina fall
08/07ILLUMINA : to Webcast Upcoming Investor Conference Presentation
08/07ILLUMINA : Court Upholds Patent Eligibility Of "Method Of Preparation" Claims In..
08/06ILLUMINA : Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discov..
More news
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 343,67 $
Last Close Price 353,35 $
Spread / Highest target 13,2%
Spread / Average Target -2,74%
Spread / Lowest Target -37,7%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.6.51%51 589
THERMO FISHER SCIENTIFIC26.25%162 255
DANAHER CORPORATION31.65%143 336
INTUITIVE SURGICAL, INC.15.54%79 929
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.77.83%56 490
BOSTON SCIENTIFIC CORPORATION-13.80%55 768